Determination and metabolism of brexpiprazole following baicalin to rats by a novel developed UPLC-MS/MS

[1]  H. Sasabe,et al.  Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human , 2021, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  G. Lin,et al.  In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method , 2021, Frontiers in Pharmacology.

[3]  Xiaodan Zhang,et al.  Silybin enhances the blood concentration of brexpiprazole in rats by downregulating expression of CYP3A4 and CYP2D6. , 2020, Die Pharmazie.

[4]  Jiong Cai,et al.  Effects of 26 recombinant CYP3A4 variants on brexpiprazole metabolism. , 2020, Chemical research in toxicology.

[5]  E. C. Strickland,et al.  A Dilute and Shoot LC-MS/MS Method for Antipsychotics in Urine. , 2019, Journal of analytical toxicology.

[6]  Yan Wang,et al.  Baicalin ameliorates chronic mild stress-induced depression-like behaviors in mice and attenuates inflammatory cytokines and oxidative stress , 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  G. Lin,et al.  UPLC‐MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma , 2019, Journal of pharmaceutical and biomedical analysis.

[8]  P. Wei,et al.  A Validated Quantification Method for Brexpiprazole in Dog Plasma. , 2018, Journal of chromatographic science.

[9]  Sarah L. Greig,et al.  Brexpiprazole: First Global Approval , 2015, Drugs.

[10]  C. Bundgaard,et al.  Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[11]  Tine Bryan Stensbøl,et al.  Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[12]  H. Zou,et al.  Baicalin Inhibits IL-17-Mediated Joint Inflammation in Murine Adjuvant-Induced Arthritis , 2013, Clinical & developmental immunology.

[13]  X. Tian,et al.  Concentration-dependent inhibitory effects of baicalin on the metabolism of dextromethorphan, a dual probe of CYP2D and CYP3A, in rats. , 2013, Chemico-biological interactions.

[14]  X. Tian,et al.  Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats , 2013, Evidence-based complementary and alternative medicine : eCAM.

[15]  Li-Tao Yi,et al.  Chronic treatment with baicalin prevents the chronic mild stress-induced depressive-like behavior: Involving the inhibition of cyclooxygenase-2 in rat brain , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  O. G. Nilsen,et al.  Displacement of Bilirubin from Albumin in Plasma from Jaundiced Newborns. An In Vitro Study of Purified Chinese Herbal Constituents and Sulfisoxazole , 2011, Phytotherapy research : PTR.

[17]  J. Arnason,et al.  Natural health products and drug disposition. , 2005, Annual review of pharmacology and toxicology.